Innate Pharma (IPHA) Return on Assets (2020 - 2025)

Innate Pharma (IPHA) has 6 years of Return on Assets data on file, last reported at 0.01% in Q4 2025.

• For the quarter ending Q4 2025, Return on Assets fell 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (down 1.0% YoY), and the FY2022 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Assets for Q4 2025 stood at 0.01%, down from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q4 2022 and bottomed at 0.01% in Q4 2025.
• The 5-year median for Return on Assets is 0.0% (2021), against an average of 0.0%.
• The widest annual swing landed in 2021, when Return on Assets changed 0 bps; it then slipped 1 bps in 2024.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2021, then soared by 99 bps to 0.0% in 2022, then tumbled by 922 bps to 0.0% in 2023, then slumped by 1546 bps to 0.01% in 2024, then tumbled by 88 bps to 0.01% in 2025.
• The last three Return on Assets figures came in at 0.01% (Q4 2025), 0.01% (Q2 2025), and 0.01% (Q4 2024), per Business Quant data.

Peer Comparison